CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
SARS-CoV-2 Nucleoprotein Products
Select your SARS-CoV-2 Nucleoprotein products including PepMix™ Peptide Pools, RepliTope™ Peptide Microarrays and Antigen Peptides!
PepMix™ Peptide Pools
EMPS-WCPV-NCAP-1
Epitope Mapping Peptide Set SARS-CoV-2 (NCAP)
Set of 21 Matrix Pools and 102 individual overlapping peptides spanning the whole Nucleoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for epitope identification and mapping.
Set of 21 Matrix Pools and 102 individual overlapping peptides spanning the whole Nucleoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for epitope identification and mapping.

Epitope Mapping Peptide Set SARS-CoV-2 (NCAP)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 102 |
Further Information:
Amount | 21 Matrix pools and 102 individual peptide aliquots (5 µg each) |
Specifications | Peptide scan (optimized scan into 15 mers) |
Documentation | Protocol, Datasheet and Annotations |
Swiss-Prot ID | |
Sequence |
MSDNGPQNQRNAPRITFGGPSDSTGSNQ NGERSGARSKQRRPQGLPNNTASWFTAL TQHGKEDLKFPRGQGVPINTNSSPDDQI GYYRRATRRIRGGDGKMKDLSPRWYFYY LGTGPEAGLPYGANKDGIIWVATEGALN TPKDHIGTRNPANNAAIVLQLPQGTTLP KGFYAEGSRGGSQASSRSSSRSRNSSRN STPGSSRGTSPARMAGNGGDAALALLLL DRLNQLESKMSGKGQQQQGQTVTKKSAA EASKKPRQKRTATKAYNVTQAFGRRGPE QTQGNFGDQELIRQGTDYKHWPQIAQFA PSASAFFGMSRIGMEVTPSGTWLTYTGA IKLDDKDPNFKDQVILLNKHIDAYKTFP PTEPKKDKKKKADETQALPQRQKKQQTV TLLPAADLDDFSKQLQQSMSSADSTQA |
Protein Length (aa) | 419 |

PM-WCPV-NCAP
PepMix™ SARS-CoV-2 (NCAP)
Pool of 102 peptides derived from a peptide scan through Nucleoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
Pool of 102 peptides derived from a peptide scan through Nucleoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

PepMix™ SARS-CoV-2 (NCAP)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 102 |
Further Information:
Amount | 1 vial containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
MSDNGPQNQRNAPRITFGGPSDSTGSNQ NGERSGARSKQRRPQGLPNNTASWFTAL TQHGKEDLKFPRGQGVPINTNSSPDDQI GYYRRATRRIRGGDGKMKDLSPRWYFYY LGTGPEAGLPYGANKDGIIWVATEGALN TPKDHIGTRNPANNAAIVLQLPQGTTLP KGFYAEGSRGGSQASSRSSSRSRNSSRN STPGSSRGTSPARMAGNGGDAALALLLL DRLNQLESKMSGKGQQQQGQTVTKKSAA EASKKPRQKRTATKAYNVTQAFGRRGPE QTQGNFGDQELIRQGTDYKHWPQIAQFA PSASAFFGMSRIGMEVTPSGTWLTYTGA IKLDDKDPNFKDQVILLNKHIDAYKTFP PTEPKKDKKKKADETQALPQRQKKQQTV TLLPAADLDDFSKQLQQSMSSADSTQA |
Protein Length (aa) | 419 |

PM-SARS2-NCPMUT-1
PepMix™ SARS-CoV-2 (NCPMUT)
Pool of 23 peptides derived from a peptide scan through Nucleoprotein (mutated regions) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
Pool of 23 peptides derived from a peptide scan through Nucleoprotein (mutated regions) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

PepMix™ SARS-CoV-2 (NCPMUT)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 23 |
Further Information:
Amount | 1 vial containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence | see Datasheet |
Protein Length (aa) | 131 |

Antigen Peptides
SP-WCPV-009
SARS-CoV-2 Antigen Peptide NCAP (AFFGMSRIGMEVTPSGTW)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (AFFGMSRIGMEVTPSGTW)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-001
SARS-CoV-2 Antigen Peptide NCAP (ALNTPKDHI)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (ALNTPKDHI)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-042
SARS-CoV-2 Antigen Peptide NCAP (ANKDGIIWVATEGAL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (ANKDGIIWVATEGAL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-008
SARS-CoV-2 Antigen Peptide NCAP (AQFAPSASAFFGMSR)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (AQFAPSASAFFGMSR)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-007
SARS-CoV-2 Antigen Peptide NCAP (AQFAPSASAFFGMSRIGM)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (AQFAPSASAFFGMSRIGM)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-043
SARS-CoV-2 Antigen Peptide NCAP (GDAALALLLLDRLNQ)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (GDAALALLLLDRLNQ)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-034
SARS-CoV-2 Antigen Peptide NCAP (GMEVTPSGTWLTYTGAIK)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (GMEVTPSGTWLTYTGAIK)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-010
SARS-CoV-2 Antigen Peptide NCAP (GMSRIGMEV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (GMSRIGMEV)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-033
SARS-CoV-2 Antigen Peptide NCAP (IGMEVTPSGTWLTYT)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (IGMEVTPSGTWLTYT)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-045
SARS-CoV-2 Antigen Peptide NCAP (IKLDDKDPNFKDQVILL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (IKLDDKDPNFKDQVILL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-013
SARS-CoV-2 Antigen Peptide NCAP (ILLNKHID)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (ILLNKHID)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-012
SARS-CoV-2 Antigen Peptide NCAP (ILLNKHIDA)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (ILLNKHIDA)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-005
SARS-CoV-2 Antigen Peptide NCAP (IRQGTDYKHWPQIAQFA)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (IRQGTDYKHWPQIAQFA)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-006
SARS-CoV-2 Antigen Peptide NCAP (KHWPQIAQFAPSASAFF)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (KHWPQIAQFAPSASAFF)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-029
SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-003
SARS-CoV-2 Antigen Peptide NCAP (LALLLLDRL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (LALLLLDRL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-004
SARS-CoV-2 Antigen Peptide NCAP (LLLDRLNQL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (LLLDRLNQL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-014
SARS-CoV-2 Antigen Peptide NCAP (LLNKHIDAYKTFPPTEPK)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (LLNKHIDAYKTFPPTEPK)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-002
SARS-CoV-2 Antigen Peptide NCAP (LQLPQGTTL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (LQLPQGTTL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-011
SARS-CoV-2 Antigen Peptide NCAP (MEVTPSGTWL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (MEVTPSGTWL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-046
SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-031
SARS-CoV-2 Antigen Peptide NCAP (QKRTATKAYNVTQAF)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (QKRTATKAYNVTQAF)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-030
SARS-CoV-2 Antigen Peptide NCAP (RLNQLESKM)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (RLNQLESKM)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-016
SARS-CoV-2 Antigen Peptide NCAP (RRPQGLPNNTASWFT)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (RRPQGLPNNTASWFT)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-036
SARS-CoV-2 Antigen Peptide NCAP (RRPQGLPNNTASWFT)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (RRPQGLPNNTASWFT)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-032
SARS-CoV-2 Antigen Peptide NCAP (TKAYNVTQAF)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (TKAYNVTQAF)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-035
SARS-CoV-2 Antigen Peptide NCAP (TPSGTWLTYTGAIKL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (TPSGTWLTYTGAIKL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-044
SARS-CoV-2 Antigen Peptide NCAP (TWLTYTGAIKLDDKDPNF)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (TWLTYTGAIKLDDKDPNF)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-049
SARS-CoV-2 Antigen Peptide NCAP (TWLTYTGAIKLDDKDPNFKDQVILL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (TWLTYTGAIKLDDKDPNFKDQVILL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-015
SARS-CoV-2 Antigen Peptide NCAP (YKTFPPTEPKKDKKKK)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (YKTFPPTEPKKDKKKK)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

RepliTope™ Peptide Microarrays
RT-MW-WCPV-NCAP
Multiwell RepliTope™ SARS-COV-2 (NCAP)
Peptide microarray displaying 102 peptides derived from a peptide scan through the whole Nucleocapsid protein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). Incubation with 20 samples (and one control) in parallel using the Array
Peptide microarray displaying 102 peptides derived from a peptide scan through the whole Nucleocapsid protein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). Incubation with 20 samples (and one control) in parallel using the Array

Multiwell RepliTope™ SARS-COV-2 (NCAP)

Application |
Antibody epitope discovery Immune monitoring |
Protein Name | Nucleoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 102 |
Further Information:
Amount | 1 peptide microarray (each peptide is deposited 3x per subarray, 21 subarrays per slide) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol, Datasheet, gal-file and gal-viewer |
Swiss-Prot ID | |
Sequence |
MSDNGPQNQRNAPRITFGGPSDSTGSNQ NGERSGARSKQRRPQGLPNNTASWFTAL TQHGKEDLKFPRGQGVPINTNSSPDDQI GYYRRATRRIRGGDGKMKDLSPRWYFYY LGTGPEAGLPYGANKDGIIWVATEGALN TPKDHIGTRNPANNAAIVLQLPQGTTLP KGFYAEGSRGGSQASSRSSSRSRNSSRN STPGSSRGTSPARMAGNGGDAALALLLL DRLNQLESKMSGKGQQQQGQTVTKKSAA EASKKPRQKRTATKAYNVTQAFGRRGPE QTQGNFGDQELIRQGTDYKHWPQIAQFA PSASAFFGMSRIGMEVTPSGTWLTYTGA IKLDDKDPNFKDQVILLNKHIDAYKTFP PTEPKKDKKKKADETQALPQRQKKQQTV TLLPAADLDDFSKQLQQSMSSADSTQA |
Protein Length (aa) | 419 |

News
NEW: SARS-COV-2 B.1.1.7(UK) & HCoV NCAP PepMixesTM
(Jan 2021)
Read more
13 NEW Immunopeptidomics Kits
References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more
Infectious diseases beyond COVID-19
JPT's peptide formats in the literature
(Oct 2020)
Read more
SARS COV-2 Mass Spec Reference Kit Released!:
SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more
Quality Assurance
All production is performed according to ISO 9001:2015 standards.